<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Vascular Endothelial Growth Factors on Michael’s Domain</title><link>https://jeltsch.org/en/tags/vascular-endothelial-growth-factors/</link><description>Recent content in Vascular Endothelial Growth Factors on Michael’s Domain</description><generator>Hugo</generator><language>en-us</language><copyright>Copyright © 2002 - 2026 Michael Jeltsch.</copyright><lastBuildDate>Fri, 24 Jul 2026 00:18:18 +0300</lastBuildDate><atom:link href="https://jeltsch.org/en/tags/vascular-endothelial-growth-factors/index.xml" rel="self" type="application/rss+xml"/><item><title>Review published in Duodecim: Lymphatics and the eye</title><link>https://jeltsch.org/en/review_published_in_duodecim_lymphatics_and_the_eye/</link><pubDate>Fri, 28 Aug 2020 00:00:00 +0000</pubDate><guid>https://jeltsch.org/en/review_published_in_duodecim_lymphatics_and_the_eye/</guid><description>&lt;p&gt;English is overwhelmingly the number one language in science. Nevertheless, sometimes there is a need to target audiences different from academic researchers. In Finland, the bi-weekly 
 &lt;a href="https://duodecimlehti.fi" target="_blank" rel="noopener noreferrer nofollow"&gt;Duodecim&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 is arguably the medical journal with the biggest reach among domestic medical professionals. Hence, the idea for a Finnish language review was born. Viewed from three different angles (from the laboratories of Sirpa Loukovaara, Kaisa Lehti, and Michael Jeltsch), we are looking at proliferative diabetic retinopathy (PDR), which is an eye complication that develops slowly over decades in diabetic patients and which is still a major cause of blindness. The treatment of PDR is often less successful than it potentially could be. Importantly, we present also advances in PDR research, from which new ideas might emerge of how to improve current treatment regimens.The original Finnish language version of the review just went online: 
 &lt;a href="https://www.duodecimlehti.fi/lehti/2020/16/duo15739" target="_blank" rel="noopener noreferrer nofollow"&gt;https://www.duodecimlehti.fi/lehti/2020/16/duo15739&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
. An English translation is available from Zenodo: 
 &lt;a href="https://doi.org/10.5281/zenodo.4005517" target="_blank" rel="noopener noreferrer nofollow"&gt;https://doi.org/10.5281/zenodo.4005517&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
.&lt;/p&gt;</description></item></channel></rss>